Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective study

Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective study

ObjectivesTo compare the safety and efficacy of lenvatinib (LEN) combined with camrelizumab plus transcatheter arterial chemoembolization (TACE-LEN-C) and TACE combined with LEN (TACE-LEN) in patients with unresectable hepatocellular carcinoma (uHCC).MethodsEighty-three patients with uHCC treated wi...

Full description

Bibliographic Details
Main Authors: Bo Sun, Lijie Zhang, Tao Sun, Yanqiao Ren, Yanyan Cao, Weihua Zhang, Licheng Zhu, Yusheng Guo, Yuxi Gui, Fengyong Liu, Lei Chen, Fu Xiong, Chuansheng Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oncology
Subjects:
lenvatinib
transcatheter arterial chemoembolization
camrelizumab
hepatocellular carcinoma
efficacy
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.982948/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.982948/full

Similar Items